N/A N=68 Screening

Feasibility Study of Retinal Screening Using the RetinaVue 100 Camera in Outpatient Dialysis Centers

Kidney Failure, Chronic · Eye Diseases · Diabetic Retinopathy

Bottom Line

View on ClinicalTrials.gov: NCT02823600 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Jul 2018

Primary outcome: Primary: Usability of the RetinaVue Hand-Held 100 Camera — 20; 116 Retinal Images

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: RetinaVue 100 camera (Device)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: University of North Carolina, Chapel Hill
Primary completion: May 2017

Outcome Measures

Outcome	Result	p-value
PRIMARY Usability of the RetinaVue Hand-Held 100 Camera	20; 116	—
SECONDARY Overall Retinopathy in a Dialysis Population	33; 35	—
SECONDARY Participant Satisfaction	61.5; 28.2; 10.3; 0; 0; 75.4	—
SECONDARY Pre-and Post-eye Exam Rates in the Diabetic Dialysis Population	—	—

Summary

The purpose of this research study is to look at retinal abnormalities in outpatient renal dialysis patients using the FDA approved RetinaVue 100 hand-held (non-mydriatic) camera.

Eligibility Criteria

Inclusion Criteria

The subject must currently be seeking treatment for end-stage renal disease (ESRD) at one of the specified dialysis clinics.
The subject must be ≥ 18 years of age.

Exclusion Criteria

The subject is <18 years of age.
No exclusions will be made on the basis of gender, ethnicity, or race.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02823600). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.